STIP1、HE4和CA125对卵巢癌的诊断(英文) 被引量：2

STIP1,HE4 and CA125 diagnostic performances for ovarian cancer

下载PDF

导出

摘要 Although many tumor markers have been identified and studied in epithelial ovarian cancer,a potential and useful screening marker for ovarian cancer has not been yet clearly established. Ovarian cancer is considered as a "silent killer"because of the absence of specific symptoms until late stage. Several validated biomarkers are currently used to diagnose and monitor the progression of the cancer,but very few of them show adequate specificity and sensitivity for different population screening. There is therefore an urge need to find biomarkers with high diagnostic accuracy and set up screening programs which can help detect ovarian cancer early,predict the response of the patient to anticancer therapy and guide physicians in choosing the best treatment for the patient. CA125,HE4 and STIP1 have been proven to play an important role as biomarkers in detecting and monitoring ovarian cancer. In this paper,we review evaluate,and highlight the role of CA125,HE4 and STIP1 in the detection of ovarian cancer.Potential biomarkers can help us distinguish malignancy from benign pelvic mass. Although many tumor markers have been identified and studied in epithelial ovarian cancer, a potential and useful screening marker for ovarian cancer has not been yet clearly established. Ovarian cancer is considered as a ＂silent killer＂ because of the absence of specific symptoms until late stage. Several validated biomarkers are currently used to diagnose and monitor the progression of the cancer, but very few of them show adequate specificity and sensitivity for different population screening. There is therefore an urge need to find biomarkers with high diagnostic accuracy and set up screening programs which can help detect ovarian cancer early, predict the response of the patient to anticancer therapy and guide physicians in choosing the best treatment for the patient. CA125, HE4 and STIP1 have been proven to play an important role as biomarkers in detecting and monitoring ovarian cancer. In this paper,we review evaluate, and highlight the role of CA125, HE4 and STIP1 in the detection of ovarian cancer. Potential biomarkers can help us distinguish malignancy from benign pelvic mass.

作者 ADZABE Luckresse 蔡云朗

机构地区 Department of Gynecology and Obstetrics

出处《东南大学学报（医学版）》 CAS 2014年第6期811-815,共5页 Journal of Southeast University(Medical Science Edition)

关键词 ovarian cancer stress-induced phosphoprotein1 human epididymis protein4 cancer antigen 125 early diagnosis ovarian cancer stress-induced phosphoproteinl human epididymis protein4 cancer antigen 125 early diagnosis

分类号 R737.31 [医药卫生—肿瘤]

引文网络
相关文献

参考文献33

1PFISTERER J, HARTER P, SIMONELLI C, et al. Abagovomabfor ovarian cancer[ J]. Expert Opin Biol Ther,2011,11 (3) : 395-403.
2SCHORGE J O, McCANN C, del CARMEN M G. Surgical de- bulking of ovarian cancer :what difference does it make? [ J]. Rev Obstet Gyneco1,2010,3 ( 3 ) : 1 11-117.
3BAST R C, FEENEY M, LAZARUS H, et al. Reactivity of a monoclonal antibody with human ovarian carcinoma[ J]. J Clin Invest, 1981,68,1331 - 1337.
4STURGEON C M, DUFFY M J, STENMAN U H, et al. National Academy of Clinical Biochemistry laboratory Medicine Practice Guidelines for use of tumor markers in testicular, prostate, colorectal, breast, and ovarian cancers [ J ]. Clin Chem, 2008, 54(12) :e1 1-79.
5ESCUDERO J M, AUGE J M, FILELLA X, et al. Comparison of serum human epididymis protein 4 with cancer antigen 125 as a tumor marker in patients with malignant and nonmalignant diseases[ J]. Clin Chem ,2011,57 : 1534-1544.
6BAST R C, BADGWELL D, LU Z, et al. New tumor markers: CA125 and beyond [ J ]. Int Gynecol Cancer, 2005,15 : 274- 281.
7PARTHA M D, ROBERT C B Jr. Early detection of ovarian cancer [ J ]. Biomark Med, 2008,2 (3) :291- 303.
8HOGDALL E V,CHRISTENSEN L,KJAER S K,et al. CA125 expression pattern, prognosis and correlation, with serum CA125 in ovarian tumor patients. From the Danish "MALOVA" Ovari- an Cancer Study[J]. Gynecol Oncol,2007,104(3) :508-515.
9KIRCHOFF C, HABBEN I, IVELL R, et al. A major human epididymis-specific cDNA encodes a protein with sequence ho- mology to extracellular proteinase inhibitors [ J ]. Biol Reprod, 1991,45:350-357.
10JIANG S W, CHEN H, DOWDY S, et al. HE4 transcription- and splice variants-specific expression in endometrial cancer and correlation with patient survival[ J]. Int J Mol Sci,2013, 14( 11 ) :22655-22677.